Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review

Objective: To analyze the clinical manifestations, imaging features and prognosis of the patients with anti-myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD). Methods: The data of eight MOGAD patients diagnosed in our hospital from January 2018 to December 2021 was analyzed, inclu...

Full description

Bibliographic Details
Main Author: LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing
Format: Article
Language:zho
Published: Editorial Office of Journal of Diagnostics Concepts & Practice 2022-10-01
Series:Zhenduanxue lilun yu shijian
Subjects:
Online Access:https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1674993704881-1090961243.pdf
_version_ 1811175557178589184
author LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing
author_facet LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing
author_sort LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing
collection DOAJ
description Objective: To analyze the clinical manifestations, imaging features and prognosis of the patients with anti-myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD). Methods: The data of eight MOGAD patients diagnosed in our hospital from January 2018 to December 2021 was analyzed, including the pathogenic factors, onset forms, clinical manifestations and auxiliary examinations. The therapeutic effect and prognosis of the patients were observed and discussed, and the relevant literatures were reviewed. Results: Among 8 patients with MOGAD, 6 were male and 2 were female, and the average age was 27.37 years. The most common clinical manifestations were limb weakness, limb twitching and blurred vision. The spinal puncture showed that the CSF pressure of the patients were 95-225 mmH2O. It revealed that 3 cases had increased CSF pressure, 5 cases had increased CSF cell count and 4 cases had increased CSF protein, while the CSF sugar and chloride were all normal. Six patients had positive MOG antibody in blood and cerebrospinal fluid. Five cases were found to have abnormal brain evoked potentials, and 4 cases had abnormal electroencephalogram. The brain MRI showed that the wide area of brain was affected, including different degree of abnormal signals in optic nerve, pons arm, thalamus, paraventricular, corpus callosum, frontal lobe, parietal lobe, occipital lobe, subcortical, cerebellum and other parts. Seven patients showed intracranial lesions, while only one patient showed abnormal signals in the long segment of cervical and thoracic spinal cord. All 8 patients were treated with high-dose methylprednisolone pulse therapy, in which 3 cases were given methylprednisolone combined with gamma globulin, and 1 case was treated with methylprednisolone combined with cyclophosphamide. After regular treatment, 7 patients were followed up for 3 years. The symptoms were relieved in 7 patients, while 1 patient still had recurrent attacks. By searching CNKI, CSPD,and CSTJD and PubMed Databases, 161 patients with MOGAD were enrolled. After reviewing the relevant literatures, it revealed that the subacute and chronic onset of MOGAD was common, and its clinical manifestations were diverse. The imaging study showed that the whole brain and spinal cord could be affected, and the recurrence rate was 30.00%-43.39%. The MOGAD patients were sensitive to hormone and immune therapy. The clinical and imaging manifestations and treatment prognosis of 8 MOGAD cases were consistent with previous report. Conclusions: The subacute and chronic onset of MOGAD is common, and most of the patients are young, and the patients show diverse clinical manifestations. In MOGAD patients, the routine examination of cerebrospinal fluid is non-specific, while the imaging of the whole brain and spinal cord are abnormal, and the damage area could be widely. The patients with MOGAD are sensitive to hormone and immune therapy, which presents satisfied therapeutic effects and prognosis. For the suspected patients, MOG should be performed as early as possible, and the multiple tests can be performed to avoid missed diagnosis.
first_indexed 2024-04-10T19:37:43Z
format Article
id doaj.art-769f148d8c284d158b2eb522a08de7f2
institution Directory Open Access Journal
issn 1671-2870
language zho
last_indexed 2024-04-10T19:37:43Z
publishDate 2022-10-01
publisher Editorial Office of Journal of Diagnostics Concepts & Practice
record_format Article
series Zhenduanxue lilun yu shijian
spelling doaj.art-769f148d8c284d158b2eb522a08de7f22023-01-30T01:10:41ZzhoEditorial Office of Journal of Diagnostics Concepts & PracticeZhenduanxue lilun yu shijian1671-28702022-10-01210560661210.16150/j.1671-2870.2022.05.010Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature reviewLIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing01a. Department of Neurology, 1b. Department of Psychiatry, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;2. Department of Neurology, First People′s Hospital of Tianshui, Gansu Province, Gansu Tianshui 741000, ChinaObjective: To analyze the clinical manifestations, imaging features and prognosis of the patients with anti-myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD). Methods: The data of eight MOGAD patients diagnosed in our hospital from January 2018 to December 2021 was analyzed, including the pathogenic factors, onset forms, clinical manifestations and auxiliary examinations. The therapeutic effect and prognosis of the patients were observed and discussed, and the relevant literatures were reviewed. Results: Among 8 patients with MOGAD, 6 were male and 2 were female, and the average age was 27.37 years. The most common clinical manifestations were limb weakness, limb twitching and blurred vision. The spinal puncture showed that the CSF pressure of the patients were 95-225 mmH2O. It revealed that 3 cases had increased CSF pressure, 5 cases had increased CSF cell count and 4 cases had increased CSF protein, while the CSF sugar and chloride were all normal. Six patients had positive MOG antibody in blood and cerebrospinal fluid. Five cases were found to have abnormal brain evoked potentials, and 4 cases had abnormal electroencephalogram. The brain MRI showed that the wide area of brain was affected, including different degree of abnormal signals in optic nerve, pons arm, thalamus, paraventricular, corpus callosum, frontal lobe, parietal lobe, occipital lobe, subcortical, cerebellum and other parts. Seven patients showed intracranial lesions, while only one patient showed abnormal signals in the long segment of cervical and thoracic spinal cord. All 8 patients were treated with high-dose methylprednisolone pulse therapy, in which 3 cases were given methylprednisolone combined with gamma globulin, and 1 case was treated with methylprednisolone combined with cyclophosphamide. After regular treatment, 7 patients were followed up for 3 years. The symptoms were relieved in 7 patients, while 1 patient still had recurrent attacks. By searching CNKI, CSPD,and CSTJD and PubMed Databases, 161 patients with MOGAD were enrolled. After reviewing the relevant literatures, it revealed that the subacute and chronic onset of MOGAD was common, and its clinical manifestations were diverse. The imaging study showed that the whole brain and spinal cord could be affected, and the recurrence rate was 30.00%-43.39%. The MOGAD patients were sensitive to hormone and immune therapy. The clinical and imaging manifestations and treatment prognosis of 8 MOGAD cases were consistent with previous report. Conclusions: The subacute and chronic onset of MOGAD is common, and most of the patients are young, and the patients show diverse clinical manifestations. In MOGAD patients, the routine examination of cerebrospinal fluid is non-specific, while the imaging of the whole brain and spinal cord are abnormal, and the damage area could be widely. The patients with MOGAD are sensitive to hormone and immune therapy, which presents satisfied therapeutic effects and prognosis. For the suspected patients, MOG should be performed as early as possible, and the multiple tests can be performed to avoid missed diagnosis.https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1674993704881-1090961243.pdf|anti-myelin oligodendrocyte glycoprotein-igg associated disorders(mogad)|clinical features|cerebrospinal fluid|electroencephalography|brain evoked potential|brain magnetic resonance
spellingShingle LIN Xia, GAO Chao, HUANG Pei, WANG Gang, LIN Guozhen, REN Rujing
Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
Zhenduanxue lilun yu shijian
|anti-myelin oligodendrocyte glycoprotein-igg associated disorders(mogad)|clinical features|cerebrospinal fluid|electroencephalography|brain evoked potential|brain magnetic resonance
title Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
title_full Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
title_fullStr Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
title_full_unstemmed Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
title_short Analysis of clinical and imaging manifestations in 8 patients with MOGAG and literature review
title_sort analysis of clinical and imaging manifestations in 8 patients with mogag and literature review
topic |anti-myelin oligodendrocyte glycoprotein-igg associated disorders(mogad)|clinical features|cerebrospinal fluid|electroencephalography|brain evoked potential|brain magnetic resonance
url https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1674993704881-1090961243.pdf
work_keys_str_mv AT linxiagaochaohuangpeiwangganglinguozhenrenrujing analysisofclinicalandimagingmanifestationsin8patientswithmogagandliteraturereview